OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
TGFβ Drives Metabolic Perturbations during Epithelial Mesenchymal Transition in Pancreatic Cancer: TGFβ Induced EMT in PDAC
Meena Rajagopal, Shivani Bansal, Prabhjit Kaur, et al.
Cancers (2021) Vol. 13, Iss. 24, pp. 6204-6204
Open Access | Times Cited: 12
Meena Rajagopal, Shivani Bansal, Prabhjit Kaur, et al.
Cancers (2021) Vol. 13, Iss. 24, pp. 6204-6204
Open Access | Times Cited: 12
Showing 12 citing articles:
Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments
Zhennan Yuan, Yingpu Li, Sifan Zhang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 375
Zhennan Yuan, Yingpu Li, Sifan Zhang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 375
Tunable hybrid hydrogels with multicellular spheroids for modeling desmoplastic pancreatic cancer
Menekşe Ermis, Natashya Falcone, Natan Roberto de Barros, et al.
Bioactive Materials (2023) Vol. 25, pp. 360-373
Open Access | Times Cited: 24
Menekşe Ermis, Natashya Falcone, Natan Roberto de Barros, et al.
Bioactive Materials (2023) Vol. 25, pp. 360-373
Open Access | Times Cited: 24
Vactosertib, TGF-β receptor I inhibitor, augments the sensitization of the anti-cancer activity of gemcitabine in pancreatic cancer
Ji Eun Lee, Pureunchowon Lee, Young‐Chan Yoon, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114716-114716
Open Access | Times Cited: 17
Ji Eun Lee, Pureunchowon Lee, Young‐Chan Yoon, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114716-114716
Open Access | Times Cited: 17
Combination treatment of T1-44, a PRMT5 inhibitor with Vactosertib, an inhibitor of TGF-β signaling, inhibits invasion and prolongs survival in a mouse model of pancreatic tumors
Eunji Hong, Wojciech Barczak, Sujin Park, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 2
Open Access | Times Cited: 16
Eunji Hong, Wojciech Barczak, Sujin Park, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 2
Open Access | Times Cited: 16
Recent Advances and Challenges in the Treatment of Advanced Pancreatic Cancer: An Update on Completed and Ongoing Clinical Trials
Archana Shenoy, Amar Yousif, Muhammad Delwar Hussain
Cancers (2025) Vol. 17, Iss. 8, pp. 1319-1319
Open Access
Archana Shenoy, Amar Yousif, Muhammad Delwar Hussain
Cancers (2025) Vol. 17, Iss. 8, pp. 1319-1319
Open Access
Targeting Tumor Microenvironment Akt Signaling Represents a Potential Therapeutic Strategy for Aggressive Thyroid Cancer
Saied Mirshahidi, Isabella J. Yuan, Alfred Simental, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5471-5471
Open Access | Times Cited: 4
Saied Mirshahidi, Isabella J. Yuan, Alfred Simental, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5471-5471
Open Access | Times Cited: 4
TGFB2 mRNA Levels Prognostically Interact with Interferon-Alpha Receptor Activation of IRF9 and IFI27, and an Immune Checkpoint LGALS9 to Impact Overall Survival in Pancreatic Ductal Adenocarcinoma
Sanjive Qazi, Vuong Trieu
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11221-11221
Open Access | Times Cited: 1
Sanjive Qazi, Vuong Trieu
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11221-11221
Open Access | Times Cited: 1
Integrative proteomics and n-glycoproteomics reveal the synergistic anti-tumor effects of aspirin- and gemcitabine-based chemotherapy on pancreatic cancer cells
Xiaoyu Li, Ran Kong, Wenhao Hou, et al.
Cellular Oncology (2023) Vol. 47, Iss. 1, pp. 141-156
Closed Access | Times Cited: 3
Xiaoyu Li, Ran Kong, Wenhao Hou, et al.
Cellular Oncology (2023) Vol. 47, Iss. 1, pp. 141-156
Closed Access | Times Cited: 3
A pancreatic adenocarcinoma mimicking hepatoid carcinoma of uncertain histogenesis: A case report and literature review
Andreea Ilieşiu, Radu-Valeriu Toma, Ana Ciongariu, et al.
Oncology Letters (2023) Vol. 26, Iss. 4
Open Access | Times Cited: 1
Andreea Ilieşiu, Radu-Valeriu Toma, Ana Ciongariu, et al.
Oncology Letters (2023) Vol. 26, Iss. 4
Open Access | Times Cited: 1
An Optimized Method for LC–MS-Based Quantification of Endogenous Organic Acids: Metabolic Perturbations in Pancreatic Cancer
Shreyans K. Jain, Shivani Bansal, Sunil Bansal, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5901-5901
Open Access
Shreyans K. Jain, Shivani Bansal, Sunil Bansal, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5901-5901
Open Access
TGF-β Signaling Loop in Pancreatic Ductal Adenocarcinoma Activates Fibroblasts and Increases Tumor Cell Aggressiveness
Noemi di Miceli, Chiara Baioni, Linda Barbieri, et al.
Cancers (2024) Vol. 16, Iss. 21, pp. 3705-3705
Open Access
Noemi di Miceli, Chiara Baioni, Linda Barbieri, et al.
Cancers (2024) Vol. 16, Iss. 21, pp. 3705-3705
Open Access
Epithelial-Mesenchymal Transition in Gastrointestinal Cancer: From a Basic to a Clinical Approach
Simona Gurzu, Ioan Jung
(2022), pp. 45-67
Closed Access
Simona Gurzu, Ioan Jung
(2022), pp. 45-67
Closed Access
